HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bacillus anthracis lethal toxin reduces human alveolar epithelial barrier function.

Abstract
The lung is the site of entry for Bacillus anthracis in inhalation anthrax, the deadliest form of the disease. Bacillus anthracis produces virulence toxins required for disease. Alveolar macrophages were considered the primary target of the Bacillus anthracis virulence factor lethal toxin because lethal toxin inhibits mouse macrophages through cleavage of MEK signaling pathway components, but we have reported that human alveolar macrophages are not a target of lethal toxin. Our current results suggest that, unlike human alveolar macrophages, the cells lining the respiratory units of the lung, alveolar epithelial cells, are a target of lethal toxin in humans. Alveolar epithelial cells expressed lethal toxin receptor protein, bound the protective antigen component of lethal toxin, and were subject to lethal-toxin-induced cleavage of multiple MEKs. These findings suggest that human alveolar epithelial cells are a target of Bacillus anthracis lethal toxin. Further, no reduction in alveolar epithelial cell viability was observed, but lethal toxin caused actin rearrangement and impaired desmosome formation, consistent with impaired barrier function as well as reduced surfactant production. Therefore, by compromising epithelial barrier function, lethal toxin may play a role in the pathogenesis of inhalation anthrax by facilitating the dissemination of Bacillus anthracis from the lung in early disease and promoting edema in late stages of the illness.
AuthorsMarybeth Langer, Elizabeth Stewart Duggan, John Leland Booth, Vineet Indrajit Patel, Ryan A Zander, Robert Silasi-Mansat, Vijay Ramani, Tibor Zoltan Veres, Frauke Prenzler, Katherina Sewald, Daniel M Williams, Kenneth Mark Coggeshall, Shanjana Awasthi, Florea Lupu, Dennis Burian, Jimmy Dale Ballard, Armin Braun, Jordan Patrick Metcalf
JournalInfection and immunity (Infect Immun) Vol. 80 Issue 12 Pg. 4374-87 (Dec 2012) ISSN: 1098-5522 [Electronic] United States
PMID23027535 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Actins
  • Antigens, Bacterial
  • Bacterial Toxins
  • Calcium-Binding Proteins
  • Membrane Proteins
  • Muscle Proteins
  • Receptors, Peptide
  • anthrax toxin
  • anthrax toxin receptors
  • Mixed Function Oxygenases
  • ASPH protein, human
Topics
  • Actins (metabolism)
  • Alveolar Epithelial Cells (cytology, drug effects, metabolism, microbiology)
  • Animals
  • Anthrax (microbiology, pathology)
  • Antigens, Bacterial (genetics, toxicity)
  • Bacillus anthracis (genetics, metabolism, pathogenicity)
  • Bacterial Toxins (genetics, toxicity)
  • Calcium-Binding Proteins (genetics, metabolism)
  • Cells, Cultured
  • Humans
  • Membrane Proteins (genetics, metabolism)
  • Mice
  • Mixed Function Oxygenases (genetics, metabolism)
  • Muscle Proteins (genetics, metabolism)
  • Receptors, Peptide (genetics, metabolism)
  • Respiratory Tract Infections (microbiology, pathology)
  • Virulence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: